Literature DB >> 6345728

The National Traumatic Coma Data Bank. Part 1: Design, purpose, goals, and results.

L F Marshall, D P Becker, S A Bowers, C Cayard, H Eisenberg, C R Gross, R G Grossman, J A Jane, S C Kunitz, R Rimel, K Tabaddor, J Warren.   

Abstract

This paper describes the pilot phase of the National Traumatic Coma Data Bank, a cooperative effort of six clinical head-injury centers in the United States. Data were collected on 581 hospitalized patients with severe non-penetrating traumatic head injury. Severe head injury was defined on the basis of a Glasgow Coma Scale (GCS) score of 8 or less following nonsurgical resuscitation or deterioration to a GCS score of 8 or less within 48 hours after head injury. A common data collection protocol, definitions, and data collection instruments were developed and put into use by all centers commencing in June, 1979. Extensive information was collected on pre-hospital, emergency room, intensive care, and recovery phases of patient care. Data were obtained on all patients from the time of injury until the end of the pilot study. The pilot phase of the Data Bank provides data germane to questions of interest to neurosurgeons and to the lay public. Questions are as diverse as: what is the prognosis of severe brain injury; what is the impact of emergency care; and what is the role of rehabilitation in the recovery of the severely head-injured patient?

Entities:  

Mesh:

Year:  1983        PMID: 6345728     DOI: 10.3171/jns.1983.59.2.0276

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  45 in total

1.  Hospital mortality of patients with severe traumatic brain injury is associated with serum PTX3 levels.

Authors:  Jackson da Silva Gullo; Melina Moré Bertotti; Cláudia Carvalho Pestana Silva; Marcelo Schwarzbold; Alexandre Paim Diaz; Flávia Mahatma Schneider Soares; Fernando Cini Freitas; Jean Nunes; José Tadeu Pinheiro; Edelton Flavio Morato; Rui Daniel Prediger; Marcelo Neves Linhares; Roger Walz
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

Review 2.  Neuromonitoring in neurological critical care.

Authors:  Ian F Dunn; Dilantha B Ellegala; Dong H Kim; Zachary N Litvack
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 3.  [Glasgow Coma Scale in traumatic brain injury].

Authors:  C Heim; P Schoettker; D R Spahn
Journal:  Anaesthesist       Date:  2004-12       Impact factor: 1.041

4.  Disability in young people and adults one year after head injury: prospective cohort study.

Authors:  S Thornhill; G M Teasdale; G D Murray; J McEwen; C W Roy; K I Penny
Journal:  BMJ       Date:  2000-06-17

5.  Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring.

Authors:  P M Vespa; M R Nuwer; V Nenov; E Ronne-Engstrom; D A Hovda; M Bergsneider; D F Kelly; N A Martin; D P Becker
Journal:  J Neurosurg       Date:  1999-11       Impact factor: 5.115

6.  Glasgow Coma Scale Score in Pediatric Patients with Traumatic Brain Injury; Limitations and Reliability.

Authors:  Fariborz Ghaffarpasand; Ali Razmkon; Maryam Dehghankhalili
Journal:  Bull Emerg Trauma       Date:  2013-10

7.  Changes produced by CT scanning in the outlook of severe head injury.

Authors:  S Turazzi; A Bricolo; M L Pasut; A Formenton
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

Review 8.  Perioperative management of adult traumatic brain injury.

Authors:  Deepak Sharma; Monica S Vavilala
Journal:  Anesthesiol Clin       Date:  2012-06-13

9.  Neuropsychological deficits in symptomatic minor head injury patients after concussion and mild concussion.

Authors:  B E Leininger; S E Gramling; A D Farrell; J S Kreutzer; E A Peck
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-04       Impact factor: 10.154

Review 10.  Clinical nihilism in neuroemergencies.

Authors:  J Claude Hemphill; Douglas B White
Journal:  Emerg Med Clin North Am       Date:  2009-02       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.